A new study from Professor Vadim Backman shows that restoring cellular memory prevents cancer cells’ ability to adapt to evade treatment.

A team of Memorial Sloan Kettering Cancer Center (MSK) researchers have made an important finding about why genetically ...

A new study published in Nanotechnology offers new hope for less harmful breast cancer therapy by combining two powerful, non ...

Elenagen™, a novel DNA plasmid therapy that previously demonstrated high clinical benefit and low toxicity in cancer patients, has now shown significant promise in alleviating chronic pain ...

Neoadjuvant immunotherapy is associated with high rates of event-free survival in patients with resectable melanoma.

Pfizer is positioning for a potential long-term rebound following a steep post-COVID revenue decline and a drop of over 50% ...

Panelists discuss how subcutaneous (SubQ) and intravenous (IV) oncology therapies will continue to coexist, with ...

Q2 2025 Earnings Call Transcript July 16, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.77, ...

Improvements in rural cancer care in Kentucky could be imperiled by President Trump's tax and domestic policy bill.

Advanced disease stage and use of combination treatments are linked to the highest first-year healthcare costs in Canadian ...

Emerging therapies, including antibody-drug conjugates and biomarker-driven approaches, have the potential to significantly ...